Gadopentetate dimeglumine Other names: Gadopentetic acid Gd-DTPA

Chemical formula: C₂₈H₅₄GdN₅O₂₀ Molecular mass: 547.58 g/mol PubChem compound: 55466

Therapeutic indications

Gadopentetate dimeglumine is indicated for:

Brain and spinal cord MRI

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)

Magnetic resonance imaging of brain and cervical spinal cord

For this indication, competent medicine agencies globally authorize below treatments (click for details):

0.2-0.6 ml/kg

0.2-0.4 ml/kg

Magnetic resonance imaging of whole body

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)

Magnetic resonance imaging of whole body

For this indication, competent medicine agencies globally authorize below treatments (click for details):

0.2-0.6 ml/kg

0.2-0.4 ml/kg

Magnetic resonance imaging arthrography of shoulder

Population group: only adults (18 years old or older)

For contrast enhancement in direct magnetic resonance arthrography.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

15-20 ml

Magnetic resonance imaging arthrography of elbow

Population group: only adults (18 years old or older)

For contrast enhancement in direct magnetic resonance arthrography.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

10 ml

Magnetic resonance imaging arthrography of wrist

Population group: only adults (18 years old or older)

For contrast enhancement in direct magnetic resonance arthrography.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

4 ml

Magnetic resonance imaging arthrography of finger joint

Population group: only adults (18 years old or older)

For contrast enhancement in direct magnetic resonance arthrography.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

1-2 ml

Magnetic resonance imaging arthrography of hip

Population group: only adults (18 years old or older)

For contrast enhancement in direct magnetic resonance arthrography.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

10-20 ml

Magnetic resonance imaging arthrography of knee

Population group: only adults (18 years old or older)

For contrast enhancement in direct magnetic resonance arthrography.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

25-50 ml

Magnetic resonance imaging arthrography of ankle

Population group: only adults (18 years old or older)

For contrast enhancement in direct magnetic resonance arthrography.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

12-20 ml

Contraindications

Gadopentetate dimeglumine is contraindicated in the following cases:

Severe renal impairment (GFR <30 ml/min/1.73 m²)

at least one of

Renal failure stage 5: Kidney failure (GFR <15 mL/min/1.73 m2 or dialysis)

< Previous: Overview

Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈